Tag

Alzheimer's disease

Latest content

Dr. Feng Xuan, Founder and CEO of Spear Bio

Ultra-sensitive immunoassay tech advances Alzheimer’s blood-based biomarker detection

SPEAR overcomes immunoassay complexity and sensitivity limitations in Alzheimer’s and neurodegenerative biomarker research with a homogeneous, wash-free format

2 Apr 2026

Industry NewsClinical Diagnostics

Roche receives CE mark for breakthrough Alzheimer’s plasma pTau217 blood test

12 May 2026

Industry NewsClinical Diagnostics

Lucent Diagnostics and Tempus AI partner to expand access to Alzheimer’s blood biomarker testing

8 May 2026

Product NewsClinical Diagnostics

Labcorp launches FDA-cleared blood test to support initial Alzheimer's disease assessment in primary care

5 May 2026

Webinars

How synthetic binders are transforming diagnostics and molecular biology

Available on-demand

Watch on-demand

Dr. Nicholas Ashton of Banner Health and Dr. Laurel Provencher of Spear Bio

Enhanced early Alzheimer's detection via ultra‑sensitive plasma pTau 217 measurement

Available on-demand

Watch on-demand

Advancing next-generation proteomics with single-molecule Iterative Mapping

Available on-demand

Watch on-demand

Rethinking neurodegeneration through blood-based biomarkers

Available on-demand

Watch on-demand

Editorial Articles

Editorial Article

Ultra-sensitive immunoassay tech advances Alzheimer’s blood-based biomarker detection

2 Apr 2026

Lindsey Mette, Director of Medical Affairs, Quanterix

Editorial Article

AI and the rise of blood-based biomarkers heralds new era for neurological diagnostics

8 Oct 2025

Editorial Article

New lateral flow test may detect Alzheimer's decades early

24 Sept 2025

Dried blood spot testing for Alzheimer's biomarker analysis

Editorial Article

Dried blood spot testing is revolutionizing Alzheimer’s monitoring

1 Aug 2025

Latest Videos

Cristiano Tunisi, the Neurology International Business Leader, Roche Diagnostics

SelectScience Interviews

How Roche Diagnostics is transforming Alzheimer’s diagnosis with innovative blood-based biomarkers

1 Oct 2025

SelectScience Interviews

Beckman Coulter accelerates blood-based Alzheimer’s testing

23 Jun 2025

Product News

The future of Alzheimer's biomarker testing

27 May 2025

Andy Hay, Sysmex America Ltd. and Sonia Nicholas, SelectScience, interview for CLINICAL24

SelectScience Interviews

CLINICAL24: Challenges, collaborations, and innovations in hematology

21 Oct 2024

Resources

Neuroscience research tools for Alzheimer’s including antibodies assay kits and protein biomarkers for early detection

Product Brochures